Candida biofilms on implanted biomaterials: A clinically significant problem

FEMS Yeast Research

Volumn 6, Issue 7, 2006, Pages 979-986

  Ramage, Gordon ^a   Martínez, José Pedro ^b   López Ribot, José Luis ^c  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Antifungal drug resistance; Biofilms; Biomaterials; Candida; Implant devices

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; ECHINOCANDIN; FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; BIOFILM; BREAST ENDOPROSTHESIS; CANDIDA; CANDIDIASIS; CELL SURFACE; CENTRAL VENOUS CATHETER; CONFERENCE PAPER; DENTURE; DEVICE INFECTION; ENDOTRACHEAL TUBE; EXTRACELLULAR MATRIX; FUNGAL COLONIZATION; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; IMPLANT; INFECTION RESISTANCE; MICROBIAL COLONIZATION; NONHUMAN;

BIOFILMS; CANDIDA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DENTURES; EQUIPMENT AND SUPPLIES; HUMANS; PROSTHESES AND IMPLANTS; RENAL DIALYSIS;

CANDIDA;

EID: 33749986341     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2006.00117.x     Document Type: Conference Paper

References (82)

1. Adair CG, Gorman SP, Feron BM, et al. (1999) Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intens Care Med 25: 1072-1076.
2. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K & Pitula A (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72: 6023-6031.
3. Arendorf TM & Walker DM (1987) Denture stomatitis: a review. J Oral Rehabil 14: 217-227.
4. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR & López-Ribot JL (2002) In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46: 3591-3596.
5. Baillie GS & Douglas LJ (1998a) Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 42: 1900-1905.
6. Baillie GS & Douglas LJ (1998b) Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob Agents Chemother 42: 2146-2149.
7. Baillie GS & Douglas LJ (1999) Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310: 644-656.
8. Baillie GS & Douglas LJ (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46: 397-403.
9. Bartizal K, Gill CJ, Abruzzo GK, et al. (1997) In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother 41: 2326-2332.
10. Beck-Sague C & Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National nosocomial infections surveillance system. J Infect Dis 167: 1247-1251.
11. Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D & Papadimitriou M (2003) Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. Clin Infect Dis 36: 927-931.
12. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D & Martinez JP (1998) Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 62: 130-180.
13. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001a) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
14. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ & Ghannoum MA (2001b) Antifungal resistance of Candida biofilms formed on denture acrylic in vitro. J Dent Res 80: 903-908.
15. Chang L, Tsai JS, Huang SJ & Shih CC (2003) Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 31: 34-39.
16. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M & Marrie TJ (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41: 435-464.
17. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR & Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49: 711-745.
18. Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
19. Crump JA & Collignon PJ (2000) Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 19: 1-8.
20. Dasgupta MK (2002) Biofilms and infection in dialysis patients. Semin Dial 15: 338-346.
21. Donlan RM (2001a) Biofilms and device-associated infections. Emerg Infect Dis 7: 277-281.
22. Donlan RM (2001b) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33: 1387-1392.
23. Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8: 881-890.
24. Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
25. Douglas LJ (2002) Medical importance of biofilms in Candida infections. Rev Iberoam Micol 19: 139-143.
26. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
27. Ell SR (1996) Candida 'the cancer of silastic'. J Laryngol Otol 110: 240-242.
28. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49: 53-70.
29. Francois P, Vaudaux P & Lew PD (1998) Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vasc Surg 12: 34-40.
30. Ghannoum MA (1997) Susceptibility testing of fungi and correlation with clinical outcome. J Chemother 9 (Suppl 1): 19-24.
31. Giamarellou H (2002) Nosocomial cardiac infections. J Hosp Infect 50: 91-105.
32. Gilbert P, Das J & Foley I (1997) Biofilm susceptibility to antimicrobials. Adv Dent Res 11: 160-167.
33. Gower DJ, Crone K, Alexander E Jr & Kelly DL Jr (1986) Candida albicans shunt infection: report of two cases. Neurosurgery 19: 111-113.
34. Gristina AG (1987) Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237: 1588-1595.
35. Habash M & Reid G (1999) Microbial biofilms: their development and significance for medical device-related infections. J Clinic Pharmacol 39: 887-898.
36. Harris AD, Castro J, Sheppard DC, Carmeli Y & Samore MH (1999) Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis 29: 926-928.
37. Hauser M, Hess J & Belohradsky BH (2003) Treatment of Candida albicans endocarditis: case report and a review. Infection 31: 125-127.
38. Hawser S (1996) Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. J Med Vet Mycol 34: 149-152.
39. Hawser SP & Douglas LJ (1994) Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62: 915-921.
40. Hawser SP & Douglas LJ (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39: 2128-2131.
41. Hawser SP, Baillie GS & Douglas LJ (1998) Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 47: 253-256.
42. Inglis TJ (1993) Evidence for dynamic phenomena in residual tracheal tube biofilm. Br J Anaesth 70: 22-24.
43. Inglis TJ, Millar MR, Jones JG & Robinson DA (1989) Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol 27: 2014-2018.
44. Inglis TJ, Lim TM, Ng ML, Tang EK & Hui KP (1995) Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest 108: 1049-1052.
45. Khardori N & Yassien M (1995) Biofilms in device-related infections. J Ind Microbiol 15: 141-147.
46. Koerner RJ (1997) Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. J Hosp Infect 35: 83-89.
47. Kuhn DM, Chandra J, Mukherjee PK & Ghannoum MA (2002a) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878-888.
48. Kuhn DM, George T, Chandra J, Mukherjee PK & Ghannoum MA (2002b) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773-1780.
49. Kumamoto CA (2002) Candida biofilms. Curr Opin Microbiol 5: 608-611.
50. Kurul S, Saip P & Aydin T (2002) Totally implantable venousaccess ports: local problems and extravasation injury. Lancet Oncol 3: 684-692.
51. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999-1007.
52. Lundstrom T & Sobel J (2001) Nosocomial candiduria: a review. Clin Infect Dis 32: 1602-1607.
53. Mateus C, Crow SA Jr & Ahearn DG (2004) Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 48: 3358-3366.
54. Mermel LA, Farr BM, Sherertz RJ, Raad II , O'Grady N, Harris JS & Craven DE (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32: 1249-1272.
55. Montero A, Romero J, Vargas JA, Regueiro CA, Sanchez-Aloz G, De Prados F, De la Torre A & Aragon G (2000) Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir (Wien) 142: 67-74.
56. Muehrcke DD, Lytle BW & Cosgrove DM III (1995) Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60: 538-543.
57. Mukherjee PK, Chandra J, Kuhn DM & Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71: 4333-4340.
58. Murphy K, Bradley J & James HE (2000) The treatment of Candida albicans shunt infections. Childs Nerv Syst 16: 4-7.
59. National Committee for Clinical Laboratory Standards (1997) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard. NCCLS Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
60. Neu TR, Verkerke GJ, Herrmann IF, Schutte HK, van der Mei HC & Busscher HJ (1994) Microflora on explanted silicone rubber voice prostheses: taxonomy, hydrophobicity and electrophoretic mobility. J Appl Bacteriol 76: 521-528.
61. O'Grady NP, Alexander M, Dellinger EP, et al. (2002) Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23: 759-769.
62. Phelan DM, Osmon DR, Keating MR & Hanssen AD (2002) Delayed reimplantation arthroplasty for Candida prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 34: 930-938.
63. Raad I (1998) Intravascular-catheter-related infections. Lancet 351: 893-898.
64. Raad I (2000) Management of intravascular catheter-related infections. J Antimicrob Chemother 45: 267-270.
65. Radford DR, Challacombe SJ & Walter JD (1999) Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. Crit Rev Oral Biol Med 10: 99-116.
66. Ramage G, Wickes BL & López-Ribot JL (2001a) Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 20: 42-44.
67. Ramage G, VandeWalle K, Wickes BL & López-Ribot JL (2001b) Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18: 163-170.
68. Ramage G, Vande Walle K, Wickes BL & López-Ribot JL (2001c) Biofilm formation by Candida dubliniensis. J Clin Microbiol 39: 3234-3240.
69. Ramage G, Vande Walle K, Wickes BL & López-Ribot JL (2001d) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475-2479.
70. Ramage G, Bachmann S, Patterson TF, Wickes BL & López-Ribot JL (2002a) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973-980.
71. Ramage G, Saville SP, Wickes BL & López-Ribot JL (2002b) Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68: 5459-5463.
72. Ramage G, VandeWalle K, Bachmann SP, Wickes BL & López-Ribot JL (2002c) In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46: 3634-3636.
73. Ramage G, VandeWalle K, López-Ribot JL & Wickes BL (2002d) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214: 95-100.
74. Ramage G, Tomsett K, Wickes BL, López-Ribot JL & Redding SW (2004) Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98: 53-59.
75. Ramage G, Saville SP, Thomas DP & López-Ribot JL (2005) Candida biofilms: an update. Eukaryot Cell 4: 633-638.
76. Rex JH, Pfaller MA, Galgiani JN, et al. (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on antifungal susceptibility testing of the national committee for clinical laboratory standards. Clin Infect Dis 24: 235-247.
77. Rivett AG, Perry JA & Cohen J (1986) Urinary candidiasis: a prospective study in hospital patients. Urol Res 14: 183-186.
78. Roque H, Abdelhak Y & Young BK (1999) Intra-amniotic candidiasis. Case report and meta-analysis of 54 cases. J Perinat Med 27: 253-262.
79. Viudes A, Peman J, Canton E, Ubeda P, López-Ribot JL & Gobernado M (2002) Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 21: 767-774.
80. Webb BC, Thomas CJ, Willcox MD, Harty DW & Knox KW (1998) Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Aust Dent J 43: 160-166.
81. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K & Beney J (2002) The direct cost and incidence of systemic fungal infections. Value Health 5: 26-34.
82. Yang SH, Pao JL & Hang YS (2001) Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty 16: 529-532.